LobbyingEso Solutions lobbying by quarter
Eso Solutions's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q1 2025; the issues it reports most are Defense and Health Issues.
Eso Solutions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $200K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $40K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $160K | 3 |
| Q1 2026 | $20K | 2 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Defense$250K · 4 reports
- Health issues$110K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
- Centers For Medicare and Medicaid Services (CMS)2 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $250K | 4 quarters |
| Brownstein Hyatt Farber Schreck | $100K | 3 quarters |
| Healthsperien | $10K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Brownstein Hyatt Farber Schreck | $20K |
| 04/20for Q1 | Healthsperien | Under $5,000 |
| 04/18for Q1 | Brownstein Hyatt Farber Schreck | $20K |
| 01/20for Q4 2025 | Healthsperien | $10K |
| 01/19for Q4 2025 | Brownstein Hyatt Farber Schreck | $60K |
| 01/11for Q4 2025 | Holland & Knight | $90K |
| 25/12/03for Q4 2025 | Healthsperien | Under $5,000 |
| 25/12/03for Q4 2025 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 25/11/14for Q4 2025 | Healthsperien | Under $5,000 |
| 25/10/18for Q3 2025 | Holland & Knight | $60K |
| 25/07/15for Q2 2025 | Holland & Knight | $60K |
| 25/04/11for Q1 2025 | Holland & Knight | $40K |
| 25/03/28for Q1 2025 | Holland & Knight | Under $5,000 |
| 25/03/20for Q1 2025 | Holland & Knight | Under $5,000 |